Canopy Biosciences LLC has acquired Core Diagnostics, a provider of biomarker analysis services for biopharmaceutical researchers. No financial terms were disclosed. Canopy Biosciences is backed by ...

Markets didn't move much as 2019 comes to a close. The final day of 2019 didn't bring a lot of action on Wall Street, as investors seemed content to celebrate what's been an extremely strong year for ...

Nov 9 (Reuters) - Pot producer Canopy Growth (WEED.TO), opens new tab reported a smaller second-quarter adjusted core loss on Thursday on the back of cost cuts. The company has been grappling with ...

ST. LOUIS, Dec. 4, 2019 /PRNewswire/ -- Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for ...